Gill Amarbir S, Smith Kristine A, Meeks Huong, Oakley Gretchen M, Curtin Karen, LeClair Laurie, Howe Heather, Orlandi Richard R, Alt Jeremiah A
Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Utah, Salt Lake City, UT.
Department of Otolaryngology-Head and Neck Surgery, University of Manitoba, Winnipeg, MB, Canada.
Int Forum Allergy Rhinol. 2021 Aug;11(8):1197-1206. doi: 10.1002/alr.22779. Epub 2021 Feb 24.
Chronic rhinosinusitis with asthma (CRS-A) has a significant impact on patient morbidity and quality of life. Nevertheless, little is known about the natural history of endoscopic sinus surgery (ESS) in this cohort. The objective of this study was to evaluate revision rates of ESS in CRS-A and identify risk factors associated with increased likelihood for revision surgery compared to those with CRS without asthma (CRS-alone).
The Utah Population Database was queried for patients age >18 years with CRS who underwent at least 1 ESS between 1996 and 2018. Demographic information and history of ESS were collected and compared between CRS-A and CRS-alone using chi-square tests for categorical variables and t tests for continuous variables. Risk factors for revision surgery were analyzed using Cox proportional hazard models.
A total of 33,090 patients (7693 CRS-A and 25,397 CRS-alone) were included in the final analysis. Mean follow up was 9.8 years in CRS-A and 9.1 years in CRS-alone (p < 0.001). The revision rate among patients with CRS-A (21.5%) was twice that of CRS-alone (10.8%) (p < 0.001). Among patients with CRS, a history of allergy (p < 0.001), asthma (p < 0.001), and nasal polyposis (p < 0.001) was independently associated with increased risk of revision ESS. Patients with CRS-A and nasal polyposis were 6 times more likely to require revision surgery than those with CRS-alone (p < 0.010).
The rate of revision ESS in CRS-A was twice that of CRS-alone; patients with CRS-A and nasal polyposis were 6 times more likely to require revision than those with CRS-alone. ©2021 ARSAAOA, LLC.
慢性鼻窦炎伴哮喘(CRS-A)对患者的发病率和生活质量有重大影响。然而,对于这一队列中内镜鼻窦手术(ESS)的自然病程知之甚少。本研究的目的是评估CRS-A患者中ESS的翻修率,并确定与无哮喘的慢性鼻窦炎(单纯CRS)患者相比,翻修手术可能性增加相关的危险因素。
查询犹他州人口数据库,获取1996年至2018年间年龄大于18岁且接受过至少1次ESS的CRS患者。收集人口统计学信息和ESS病史,并使用卡方检验分析分类变量,使用t检验分析连续变量,对CRS-A组和单纯CRS组进行比较。使用Cox比例风险模型分析翻修手术的危险因素。
最终分析共纳入33090例患者(7693例CRS-A患者和25397例单纯CRS患者)。CRS-A组的平均随访时间为9.8年,单纯CRS组为9.1年(p<0.001)。CRS-A患者的翻修率(21.5%)是单纯CRS患者(10.8%)的两倍(p<0.001)。在CRS患者中,过敏史(p<0.001)、哮喘史(p<0.001)和鼻息肉病史(p<0.001)与ESS翻修风险增加独立相关。CRS-A合并鼻息肉的患者需要翻修手术的可能性是单纯CRS患者的6倍(p<0.010)。
CRS-A患者的ESS翻修率是单纯CRS患者的两倍;CRS-A合并鼻息肉的患者需要翻修的可能性是单纯CRS患者的6倍。©2021 ARSAAOA,有限责任公司。